Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer
- 1 December 2016
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 109, 174-183
Abstract
No abstract availableKeywords
Funding Information
- Anadolu University Scientific Research Foundation
This publication has 51 references indexed in Scilit:
- Delivery systems for siRNA drug development in cancer therapyAsian Journal of Pharmaceutical Sciences, 2015
- RASSF tumor suppressor gene family: Biological functions and regulationFEBS Letters, 2014
- Lipid-based systemic delivery of siRNAAdvanced Drug Delivery Reviews, 2009
- Drug delivery of siRNA therapeutics: potentials and limits of nanosystemsNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Chemically modified siRNA prolonged RNA interference in renal diseaseBiochemical and Biophysical Research Communications, 2007
- Cationic lipids and polymers mediated vectors for delivery of siRNAJournal of Controlled Release, 2007
- Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA deliveryJournal of Controlled Release, 2007
- Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA deliveryVision Research, 2007
- Delivery of RNA InterferenceCell Cycle, 2006
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001